Pan-retinal photocoagulation with or without intravitreal Ranibizumab in high risk proliferative diabetic retinopathy

• Grant number: 09/01036-3
• Support Opportunities: Regular Research Grants
• Start date: June 01, 2010
• End date: November 30, 2010
• Field of knowledge: Health Sciences - Medicine
• Principal Investigator: Rodrigo Jorge
• Grantee: Rodrigo Jorge
• Host Institution: Faculdade de Medicina de Ribeirão Preto (FMRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

FILHO, JOSE A. R.; MESSIAS, ANDRE; ALMEIDA, FELIPE P. P.; RIBEIRO, JEFFERSON A. S.; COSTA, ROGERIO A.; SCOTT, INGRID U.; JORGE, RODRIGO. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy. ACTA OPHTHALMOLOGICA, v. 89, n. 7, p. E567-E572, NOV 2011. (09/01036-3)

MESSIAS, ANDRE; RAMOS FILHO, JOSE AFONSO; MESSIAS, KATHARINA; ALMEIDA, FELIPE P. P.; COSTA, ROGERIO A.; SCOTT, INGRID U.; GEKELER, FLORIAN; JORGE, RODRIGO. Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy. DOCUMENTA OPHTHALMOLOGICA, v. 124, n. 3, p. 225-236, JUN 2012. (09/01036-3)